AI-guided Detection of Heart Disease in Routine Practice
Related Articles
BOSTINNO’S 2021 INNO ON FIRE: Meet the 50 startups and individuals setting Boston’s innovation ecosystem ablaze.
Biz Journals: If 2020 was a strange year for Boston's startups, companies and nonprofits, 2021 was its equally weird sequel. But the continuing pandemic, global supply-chain shortages, economic turmoil and…{post_date: F d, Y}
Mayo Clinic, Janssen-backed venture gets FDA OK for pulmonary hypertension AI algorithm
Becker's Hospital Review: A Mayo Clinic and Janssen-backed venture has received FDA breakthrough designation for an algorithm designed to enable early detection of pulmonary hypertension. Anumana Inc. received the breakthrough…{post_date: F d, Y}
Anumana & Pfizer Partner on Amyloidosis AI-ECG Algorithm Development
HIT Consultant: Anumana, an AI-driven health technology company and portfolio company of nference, today announced a multi-year agreement with Pfizer for Anumana to develop an investigational artificial intelligence electrocardiogram algorithm…{post_date: F d, Y}
FDA Grants Breakthrough Device Designation to Anumana’s ECG Pulmonary Hypertension Early Detection AI Algorithm
Developed in collaboration with Janssen and Mayo Clinic, this technology has the potential to aid physicians in earlier detection of pulmonary hypertension, a progressive, life-threatening disease{post_date: F d, Y}